Medical diagnostics
Advances in disease detection can characterise all manner of health disorders with greater precision.
-
Produced with support from:
Working out what ails a person is a founding principle of modern medicine. And as treatments improve and become more tightly targeted, access to a precise and rapid diagnosis is more important than ever.
New technologies and techniques are enabling physicians and researchers to determine with great specificity what infection, malignancy, genetic condition or other malady is present. In some cases, they are speeding up the wait for results, and allowing diagnosis earlier in the disease course. Clearly, the world of medical diagnostics has entered a period of rapid change.
This collection will be updated throughout 2024, with reporting from journalists and research from across the Nature Portfolio journals. Follow Nature on X, Facebook and LinkedIn, and check back throughout the year to keep up with the latest additions.
Features
Original journalism from Nature.
Could rats and dogs detect disease better than the finest lab equipment?
The animals’ keen sense of smell could improve the detection of illnesses such as cancer and tuberculosis. By Sarah DeWeerdt
19 June 2024
AI's keen diagnostic eye
Powered by deep-learning algorithms, artificial intelligence systems could replace agents such as chemicals used to augment medical scans. By Neil Savage
18 April 2024
The future of at-home molecular testing
The COVID-19 pandemic showed what was possible for gene-based diagnostics. Now comes the true test - economics. By Elie Dolgin
21 March 2024
Tracking down tuberculosis
Improvements in screening and diagnosis could help to eradicate this curable disease. By Neil Savage
25 January 2024
Putting low-cost diagnostics to the test
Extending the 'good enough' approach used to detect COVID-19 to other illnesses could improve health care in low- and middle-income countries. By Michael Eisenstein
27 November 2023
Research and reviews
Curated from the Nature Portfolio journals.
Nature is pleased to acknowledge financial support from Seegene in producing this Outlook. Nature retains sole responsibility for all editorial content. About this content.
The supporting organization retains sole responsibility for the following message:
Seegene is a global molecular diagnostics company providing comprehensive solutions for healthcare through unique and proprietary technology that combines high multiplex diagnostic PCR testing with intelligent automated systems.
Seegene’s syndromic PCR assays identify up to 15 targets in a single tube (28 targets in multi tubes) with quantitative information and have unprecedentedly enhanced sensitivity, specificity, and target coverage per test. Seegene OneSystem™ enables all Seegene’s syndromic PCR assays to be run on Seegene’s automated instrument, called ‘All-In-One System’ (AIOS).
Seegene strengthens their strategic alliance with Springer Nature as the ‘Open Innovation Program powered by Seegene’ joins Nature Awards.
Everything we do should make an impact, our vision is to take a step closer to a world free from all diseases and future pandemics through syndromic PCR diagnosis in all fields.
SPONSOR FEATURES
Sponsor retains sole responsibility for the content of the below articles.
Joining forces to combat diseases with syndromic qPCR testing
Three awardees from the Open Innovations Program, a joint initiative between Seegene and Springer Nature, discuss how their projects will change the paradigm of the diagnosis of very different diseases using syndromic quantitative PCR (qPCR) testing.
Why syndromic PCR technology is key to a pandemic-proof world
Polymerase chain reaction (PCR) testing, which played such a key role in tackling the COVID-19 pandemic, could be a critical technology for addressing future threats to human health.
Groundbreaking PCR technology to halt the spread of disease
The ability to check for many pathogens simply and simultaneously will make PCR tests more powerful than ever before, says a South Korean Company which is pursuing “molecular diagnostics for a world free from all disease”.
One-stop shop for multi-pathogen PCR testing is disease-detection game changer
A company in South Korea has embarked on a bold plan to consolidate the world’s PCR library resources into a single formidable system — and then collaborate with global experts to make syndromic PCR assays more accessible.
Built with Shorthand